Skip to content
  • Services
    • Services Overview
    • ProtoTrials®
    • Flow Cytometry
    • Bioanalysis
    • Soluble Biomarkers
    • Custom Solutions
    • Technology Platforms
    • Operations
  • Therapeutic Areas
  • Resources
    • Brochures
    • Datasheets
    • Webinars
    • Feature Articles
    • Blogs
    • Events
  • About Us
    • About Synexa
    • The Team
    • News
  • Careers
    • Opportunities
    • SynErgy
  • Contact
  • Services
    • Services Overview
    • ProtoTrials®
    • Flow Cytometry
    • Bioanalysis
    • Soluble Biomarkers
    • Custom Solutions
    • Technology Platforms
    • Operations
  • Therapeutic Areas
  • Resources
    • Brochures
    • Datasheets
    • Webinars
    • Feature Articles
    • Blogs
    • Events
  • About Us
    • About Synexa
    • The Team
    • News
  • Careers
    • Opportunities
    • SynErgy
  • Contact

Archives: News

Synexa Life Sciences celebrates its 20th anniversary

Synexa Life Sciences celebrates its 20th anniversary

Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights.

Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions

Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions

Leading specialist biomarker and bioanalysis solutions provider further strengthens global management team.

Synexa Life Sciences expands operations in North America with new Rockville laboratory site

Synexa Life Sciences expands operations in North America with new Rockville laboratory site

New site supports unique and seamless workflows that narrow the gap between preclinical and clinical phases

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals.

Synexa Life Sciences announces strategic growth plans and strengthening of its executive team

Synexa Life Sciences announces strategic growth plans and strengthening of its executive team

Delivering on growth strategies to become the global market leader in specialist biomarker and bioanalytical services.

Synexa Life Sciences Co-founder and CEO to become company’s Chairman

Synexa Life Sciences Co-founder and CEO to become company’s Chairman

Leading biomarker and bioanalysis company lays the foundation for future growth and expansion plan.

Synexa Announces Tripartite Collaboration

Synexa Announces Tripartite Collaboration

Together with Paraxel and Drawbridge Health, Synexa offers a streamlined solution to COVID-19 serology testing.

Sign up to Synexa Insights
About Us
About Synexa
Leadership
SynErgy
Operations
Bioanalytical Science
Introduction
Pharmacokinetics
Immunogenicity
Resource Library
Brochures
Datasheets
Webinars
News & Insights
News
Blog Articles
Feature Articles

© Synexa Life Sciences BV 2023 | Privacy | Terms of Use | Cookies | Sitemap

Linkedin-in Twitter
  • Services
    • Services Overview
    • ProtoTrials®
    • Flow Cytometry
    • Bioanalysis
    • Soluble Biomarkers
    • Custom Solutions
    • Technology Platforms
    • Operations
  • Therapeutic Areas
  • Resources
    • Brochures
    • Datasheets
    • Webinars
    • Feature Articles
    • Blogs
    • Events
  • About Us
    • About Synexa
    • The Team
    • News
  • Careers
    • Opportunities
    • SynErgy
  • Contact
  • Sign up to Synexa Insights

News Signup

"*" indicates required fields

Consent
By submitting this form, Synexa Life Sciences will use the personal data you provide to handle your request. Read our privacy notice here more information.
This field is for validation purposes and should be left unchanged.

Talk to our Biomarker Experts

  • By submitting this form, Synexa Life Sciences will use the personal data you provide to handle your request. Read our privacy notice here more information.